Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Incretins in the Pathogenesis of Fasting and Postprandial Glucose Metabolism in People With Impaired Fasting Glucose

NCT00364377 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00364377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00364377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Incretins in the Pathogenesis of Fasting and Postprandial Glucose Metabolism in People With Impaired Fasting Glucose
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2006
Completion date
December 31, 2008
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-diabetes